Is Alzheimer's disease, relentless and slow, a better target for clinical trials?

Published Date: 16 Feb 2023

According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

2.

Obesity linked to subsequent neoplasms in childhood cancer survivors

3.

For older patients with Hodgkin lymphoma, novel regimens produce high response rates.

4.

Month-Long Wait Times Caused by US Physician Shortage.

5.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot